Skip to main content
bioRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search
New Results

Structure and inhibitor binding characterization of oncogenic MLLT1 mutants

Xiaomin Ni, Allyn T. Londregan, Dafydd R. Owen, Stefan Knapp, View ORCID ProfileApirat Chaikuad
doi: https://doi.org/10.1101/2021.02.08.430291
Xiaomin Ni
1Structural Genomics Consortium, Goethe University Frankfurt, Buchmann Institute for Molecular Life Sciences, Max-von-Laue-Straße 15, 60438 Frankfurt am Main, Germany
2Institute of Pharmaceutical Chemistry, Goethe University Frankfurt, Max-von-Laue-Straße 9, 60438 Frankfurt am Main, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Allyn T. Londregan
4Medicine Design, Pfizer Worldwide Research Development and Medicine, Eastern Point Road, Groton, CT 06340, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dafydd R. Owen
5Medicine Design, Pfizer Worldwide Research Development and Medicine, 1 Portland Street, Cambridge, MA 02139, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stefan Knapp
1Structural Genomics Consortium, Goethe University Frankfurt, Buchmann Institute for Molecular Life Sciences, Max-von-Laue-Straße 15, 60438 Frankfurt am Main, Germany
2Institute of Pharmaceutical Chemistry, Goethe University Frankfurt, Max-von-Laue-Straße 9, 60438 Frankfurt am Main, Germany
3German Cancer network DKTK and Frankfurt Cancer Institute (FCI), Goethe University Frankfurt, Frankfurt am Main, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: chaikuad@pharmchem.uni-frankfurt.de knapp@pharmchem.uni-frankfurt.de
Apirat Chaikuad
1Structural Genomics Consortium, Goethe University Frankfurt, Buchmann Institute for Molecular Life Sciences, Max-von-Laue-Straße 15, 60438 Frankfurt am Main, Germany
2Institute of Pharmaceutical Chemistry, Goethe University Frankfurt, Max-von-Laue-Straße 9, 60438 Frankfurt am Main, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Apirat Chaikuad
  • For correspondence: chaikuad@pharmchem.uni-frankfurt.de knapp@pharmchem.uni-frankfurt.de
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Preview PDF
Loading

Abstract

Dysfunction of YEATS-domain-containing MLLT1, an acetyl/acyl-lysine dependent epigenetic reader domain, has been implicated in the development of aggressive cancers. Mutations in the YEATS domain have been recently reported as a cause of MLLT1 aberrant reader function. However, structural basis for the reported alterations in affinity for acetyled/acylated histone has remained elusive. Here, we report the crystal structures of both insertion and substitution present in cancer, revealing significant conformational changes of the YEATS-domain loop 8. Structural comparison demonstrates that such alteration not only altered the binding interface for acetylated/acylated histones, but the sequence alterations in the T1 loop may enable dimeric assembly consistent inducing self-association behavior. Nevertheless, we show that also the MLLT1 mutants can be targeted by developed acetyllysine mimetic inhibitors with affinities similarly to wild type. Our report provides a structural basis for the altered behaviors and potential strategy for targeting oncogenic MLLT1 mutants.

Competing Interest Statement

Allyn T. Londregan and Dafydd R. Owen are employees of Pfizer.

  • ABBREVIATIONS

    YEATS domain
    The Yaf9, ENL, AF9, Taf14, Sas5 (YEATS) domain;
    ENL
    eleven-nineteen-leukemia protein;
    MLLT1
    myeloid/lymphoid or mixed-lineage leukemia translocated to, chromosome 1 protein;
    AF9
    ALL1-fused gene from chromosome 9 protein;
    MLLT3
    myeloid/lymphoid or mixed-lineage leukemia translocated to chromosome 3 protein.
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
    Back to top
    PreviousNext
    Posted February 08, 2021.
    Download PDF
    Email

    Thank you for your interest in spreading the word about bioRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Structure and inhibitor binding characterization of oncogenic MLLT1 mutants
    (Your Name) has forwarded a page to you from bioRxiv
    (Your Name) thought you would like to see this page from the bioRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Structure and inhibitor binding characterization of oncogenic MLLT1 mutants
    Xiaomin Ni, Allyn T. Londregan, Dafydd R. Owen, Stefan Knapp, Apirat Chaikuad
    bioRxiv 2021.02.08.430291; doi: https://doi.org/10.1101/2021.02.08.430291
    Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
    Citation Tools
    Structure and inhibitor binding characterization of oncogenic MLLT1 mutants
    Xiaomin Ni, Allyn T. Londregan, Dafydd R. Owen, Stefan Knapp, Apirat Chaikuad
    bioRxiv 2021.02.08.430291; doi: https://doi.org/10.1101/2021.02.08.430291

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Biochemistry
    Subject Areas
    All Articles
    • Animal Behavior and Cognition (4082)
    • Biochemistry (8754)
    • Bioengineering (6475)
    • Bioinformatics (23331)
    • Biophysics (11730)
    • Cancer Biology (9142)
    • Cell Biology (13235)
    • Clinical Trials (138)
    • Developmental Biology (7407)
    • Ecology (11364)
    • Epidemiology (2066)
    • Evolutionary Biology (15081)
    • Genetics (10395)
    • Genomics (14005)
    • Immunology (9114)
    • Microbiology (22033)
    • Molecular Biology (8777)
    • Neuroscience (47337)
    • Paleontology (350)
    • Pathology (1419)
    • Pharmacology and Toxicology (2480)
    • Physiology (3702)
    • Plant Biology (8044)
    • Scientific Communication and Education (1430)
    • Synthetic Biology (2206)
    • Systems Biology (6013)
    • Zoology (1248)